35671099 2024-10-01 2025-09-30 3 35671099 2024-10-01 2025-09-30 2 35671099 2024-10-01 2025-09-30 2 35671099 2024-10-01 2025-09-30 3 35671099 2024-10-01 2025-09-30 4 35671099 2024-10-01 2025-09-30 5 35671099 2024-10-01 2025-09-30 35671099 2024-10-01 2025-09-30 1 35671099 2023-10-01 2024-09-30 35671099 2025-09-30 35671099 2024-09-30 35671099 2024-10-01 d:CompletedDevelopmentProjectsMember 35671099 2025-09-30 d:CompletedDevelopmentProjectsMember 35671099 2024-10-01 2025-09-30 d:CompletedDevelopmentProjectsMember 35671099 2024-10-01 d:AcquiredIntangibleAssetsMember 35671099 2024-10-01 2025-09-30 d:AcquiredIntangibleAssetsMember 35671099 2025-09-30 d:AcquiredIntangibleAssetsMember 35671099 2024-10-01 d:FixturesFittingsToolsAndEquipmentMember 35671099 2024-10-01 2025-09-30 d:FixturesFittingsToolsAndEquipmentMember 35671099 2025-09-30 d:FixturesFittingsToolsAndEquipmentMember 35671099 2024-10-01 d:LeaseholdImprovementsMember 35671099 2024-10-01 2025-09-30 d:LeaseholdImprovementsMember 35671099 2025-09-30 d:LeaseholdImprovementsMember 35671099 2024-10-01 d:InvestmentsInGroupEnterprisesMember 35671099 2023-10-01 d:InvestmentsInGroupEnterprisesMember 35671099 2024-10-01 2025-09-30 d:InvestmentsInGroupEnterprisesMember 35671099 2023-10-01 2024-09-30 d:InvestmentsInGroupEnterprisesMember 35671099 2025-09-30 d:InvestmentsInGroupEnterprisesMember 35671099 2024-09-30 d:InvestmentsInGroupEnterprisesMember 35671099 2024-10-01 2025-09-30 d:SubsidiaryMember 1 35671099 2025-09-30 d:SubsidiaryMember 1 35671099 2024-10-01 d:DepositsLongtermInvestmentsAndReceivablesMember 35671099 2024-10-01 2025-09-30 d:DepositsLongtermInvestmentsAndReceivablesMember 35671099 2025-09-30 d:DepositsLongtermInvestmentsAndReceivablesMember 35671099 2024-10-01 d:ContributedCapitalMember 35671099 2023-10-01 d:ContributedCapitalMember 35671099 2024-10-01 2025-09-30 d:ContributedCapitalMember 35671099 2023-10-01 2024-09-30 d:ContributedCapitalMember 35671099 2025-09-30 d:ContributedCapitalMember 35671099 2024-09-30 d:ContributedCapitalMember 35671099 2024-10-01 2025-09-30 d:SharePremiumMember 35671099 2023-10-01 2024-09-30 d:SharePremiumMember 35671099 2024-10-01 2025-09-30 d:ReserveForNetRevaluationAccordingToEquityMethodMember 35671099 2023-10-01 2024-09-30 d:ReserveForNetRevaluationAccordingToEquityMethodMember 35671099 2024-10-01 d:ReserveForDevelopmentExpenditureMember 35671099 2023-10-01 d:ReserveForDevelopmentExpenditureMember 35671099 2024-10-01 2025-09-30 d:ReserveForDevelopmentExpenditureMember 35671099 2023-10-01 2024-09-30 d:ReserveForDevelopmentExpenditureMember 35671099 2025-09-30 d:ReserveForDevelopmentExpenditureMember 35671099 2024-09-30 d:ReserveForDevelopmentExpenditureMember 35671099 2024-10-01 d:ReserveForCurrentValueAdjustmentsOfCurrencyGainsMember 35671099 2023-10-01 d:ReserveForCurrentValueAdjustmentsOfCurrencyGainsMember 35671099 2024-10-01 2025-09-30 d:ReserveForCurrentValueAdjustmentsOfCurrencyGainsMember 35671099 2023-10-01 2024-09-30 d:ReserveForCurrentValueAdjustmentsOfCurrencyGainsMember 35671099 2025-09-30 d:ReserveForCurrentValueAdjustmentsOfCurrencyGainsMember 35671099 2024-09-30 d:ReserveForCurrentValueAdjustmentsOfCurrencyGainsMember 35671099 2024-10-01 d:RetainedEarningsMember 35671099 2023-10-01 d:RetainedEarningsMember 35671099 2024-10-01 2025-09-30 d:RetainedEarningsMember 35671099 2023-10-01 2024-09-30 d:RetainedEarningsMember 35671099 2025-09-30 d:RetainedEarningsMember 35671099 2024-09-30 d:RetainedEarningsMember 35671099 2024-10-01 2025-09-30 1 35671099 2024-10-01 2025-09-30 1 iso4217:DKK xbrli:pure Årsrapport 15915641 Christensen Kjærulff, Statsautoriseret Revisionsaktieselskab Østbanegade, 123 2100, København Ø 2023-10-01 2024-09-30 2024-10-01 2025-09-30 35671099 Celvivo ApS Ørbækvej 264 5220 Odense SØ 2014-02-26 Odense Christensen Kjærulff, Statsautoriseret Revisionsaktieselskab 15915641 Elan Schapiro statsautoriseret revisor mne33765 Østbanegade 123 2100 København Ø Danmark +45 33 30 15 15 ck@ck.dk 2026-03-19 Christian Knappe Regnskabsklasse B Revisionspåtegning Ja CaseWare fra Revisorgruppen Danmark kapitalejerne København 2026-03-19 Odense SØ 2026-03-19 Grundlag for konklusion Konklusion -7874886 1462586 12540301 11699722 8385666 7095350 -28800853 -17332486 1283366 -1485636 5063 0 8386067 7600840 -35898491 -26418962 9669597 -5519997 -45568088 -20898965 1283366 -1485636 -46851454 -19413329 12230873 18927063 2021235 2289264 14252108 21216327 421229 1126658 492358 602482 913587 1729140 537310 138970 537310 138970 15703005 23084437 1697144 1074680 244935 221313 1423789 2328934 3365868 3624927 1855873 2561287 3437506 954986 0 11915963 2952201 1827192 517034 403741 363469 233308 9126083 17896477 48499 44762 12540450 21566166 28243455 44650603 0 80382 65027 9540081 18858961 98627 56029 -64145124 -58692211 -54426034 -39712194 46893179 351070 136208 354884 47029387 705954 32600445 36577369 1898979 1588768 689023 45047356 451655 443350 35640102 83656843 82669489 84362797 28243455 44650603 10796675 9976292 1605561 1598472 138065 124958 12540301 11699722 15 14 33480946 33480946 14553883 6696190 21250073 12230873 3496436 431258 3927694 1207172 699287 1906459 2021235 4416813 82192 4499005 3290155 787621 4077776 421229 935317 92443 1027760 332835 202567 535402 492358 6659 7039 -302 -380 6357 6659 -1827521 -391627 42601 49742 1273293 -1459971 10073 -25665 -501554 -1827521 495197 1820862 495197 1820862 Celvivo Inc. USA 100 138970 398340 537310 537310 65027 65027 15355 0 80382 65027 30796295 0 30796295 0 1283366 -1485636 -1283366 1485636 18858961 16737652 -9318880 2121309 9540081 18858961 56029 6667 42598 49362 98627 56029 -58692211 -35671937 -46851454 -19413329 30796295 0 10602246 -3606945 -64145124 -58692211 Be­sty­rel­se og di­rek­tion har dags da­to af­lagt års­rap­por­ten for regn­skabs­året 1. oktober 2024 - 30. september 2025 for Celvivo ApS. Today, the Board of Directors and the Executive Board have approved the annual report of Celvivo ApS for the financial year 1 October 2024 - 30 September 2025. Års­rap­por­ten er af­lagt i over­ens­stem­mel­se med års­regn­skabs­lo­ven. The annual report has been prepared in accordance with the Danish Financial Statements Act. Vi an­ser den valg­te regn­skabs­prak­sis for hen­sigts­mæs­sig, og efter vores op­fat­tel­se gi­ver års­regn­ska­bet et ret­vi­sen­de bil­le­de af sel­ska­bets ak­ti­ver, pas­si­ver og fi­nan­siel­le stil­ling pr. 30. september 2025 samt af re­sul­ta­tet af sel­ska­bets ak­ti­vi­te­ter for regn­skabs­år­et 1. oktober 2024 - 30. september 2025. We consider the chosen accounting policy to be appropriate, and in our opinion, the financial statements give a true and fair view of the financial position of the Company at 30 September 2025 and of the results of the Company's operations for the financial year 1 October 2024 – 30 September 2025. Le­del­ses­be­ret­nin­gen in­de­hol­der ef­ter vores op­fat­tel­se en ret­vi­sen­de re­de­gø­rel­se for de for­hold, som be­ret­nin­gen om­hand­ler. Further, in our opinion, the Management's review gives a true and fair review of the matters discussed in the Management's review. Års­rap­por­ten ind­stil­les til ge­ne­ral­for­sam­lin­gens god­ken­del­se. We recommend that the annual report be approved at the Annual General Meeting. Peter Willems-Alnøe Søren Baisner Alnøe Administrerende direktør Patrik Olof Dahlén Lene Ploug Bülow Tonni Bülow-Nielsen Formand Dorthe Mikkelsen Krzysztof Wrzesinski Vi har re­vi­de­ret års­regn­ska­bet for Celvivo ApS for regn­skabs­året 1. oktober 2024 - 30. september 2025, der om­fat­ter an­vendt regn­skabs­prak­sis, re­sul­tat­op­gø­rel­se, ba­lan­ce, egen­ka­pi­tal­op­gø­rel­se og noter. Års­regn­ska­bet ud­ar­bej­des ef­ter års­regn­skabs­lo­ven. Det er vo­res op­fat­telse, at års­regn­ska­bet gi­ver et ret­vis­ende bil­le­de af sel­ska­bets ak­ti­ver, pas­si­ver og fi­nan­siel­le stil­ling pr. 30. september 2025 samt af re­sul­ta­tet af sel­ska­bets ak­ti­vi­te­ter for regn­skabs­år­et 1. oktober 2024 - 30. september 2025 i ov­er­ens­stem­mel­se med års­regn­skabs­lo­ven. We have audited the financial statements of Celvivo ApS for the financial year 1 October 2024 - 30 September 2025, which comprise a summary of significant accounting policies, income statement, balance sheet, statement of changes in equity and notes, for the Company. The financial statements are prepared under the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the financial position of the Company at 30 September 2025, and of the results of the Company's operations for the financial year 1 October 2024 - 30 September 2025 in accordance with the Danish Financial Statements Act. Grundlag for kon­klu­sionVi har ud­ført vo­res re­vi­si­on i over­ens­stem­mel­se med in­ter­na­tio­na­le stan­dar­der om re­vi­si­on og de yder­li­ge­re krav, der er gæl­den­de i Dan­mark. Vo­res an­svar iføl­ge dis­se stan­dar­der og krav er nær­me­re be­skre­vet i re­vi­si­ons­på­teg­nin­gens af­snit ”Re­vi­sors an­svar for re­vi­si­o­nen af års­regn­ska­bet”. Vi er uaf­hæn­gi­ge af sel­ska­bet i over­ens­stem­mel­se med In­ter­na­tio­nal Ethics Standards Board for Accountants' internationale retningslinjer for revisorers etiske adfærd (IESBA Code) og de yder­ligere etiske krav, der er gæl­den­de i Dan­mark, lige­som vi har op­fyldt vo­res øv­ri­ge etis­ke for­plig­tel­ser i hen­hold til dis­se krav og IESBA Code. Det er vo­res op­fat­tel­se, at det op­nå­e­de re­vi­si­ons­be­vis er til­stræk­ke­ligt og eg­net som grund­lag for vo­res kon­klu­sion. Basis for OpinionWe conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Den­mark. Our responsibilities under those standards and requirements are further described in the “Auditor’s Responsibilities for the Audit of the Financial Statements” section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Den­mark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Væsentlig usikkerhed vedrørende fortsat driftVi gør opmærksom på, at der fortsat er væsentlig usikkerhed om selskabets evne til at fortsætte driften. Som beskrevet i note 1 har selskabet i det nye regnskabsår modtaget DKK 20 mio. gennem en kapitalforhøjelse, og hovedanpartshavere har bekræftet, at anfordringslån ikke skal indfries i det kommende år. Selskabet fortsætter samtidig sin kapitalsøgning. På baggrund heraf vurderer ledelsen, at likviditetsberedskabet kan opretholdes, selv ved forsinket kapitalrejsning, og årsregnskabet er derfor udarbejdet under forudsætning af fortsat drift. Material Uncertainty Related to Going ConcernWe draw attention to the fact that there remains material uncertainty regarding the Company’s ability to continue as a going concern. As described in note 1, in the new financial year the Company has received DKK 20 million through a capital increase, and the principal shareholders have confirmed that shareholder loans repayable on demand will not be called for repayment in the coming year. At the same time, the Company continues its capital-raising activities. On this basis, management assesses that the Company’s liquidity position can be maintained, even in the event of a delayed capital raising, and the annual financial statements have therefore been prepared on a going concern basis. Le­del­sen har an­sva­ret for ud­ar­bej­del­sen af et års­regn­skab, der gi­ver et ret­vi­sen­de bil­le­de i over­ens­stem­mel­se med års­regn­skabs­lo­ven. Le­del­sen har end­videre an­sva­ret for den in­ter­ne kon­trol, som le­del­sen an­ser nød­ven­dig for at ud­ar­bej­de et års­regn­skab uden væ­sent­lig fejl­in­for­mation, uan­set om den­ne skyl­des be­svi­gel­ser eller fejl. Ved ud­ar­bej­del­sen af års­regn­ska­bet er le­del­sen an­svar­lig for at vur­de­re sel­ska­bets ev­ne til at fort­sæt­te drif­ten; at op­ly­se om for­hold ved­rø­ren­de fort­sat drift, hvor det­te er re­le­vant; samt at ud­ar­bej­de års­regn­ska­bet på grund­lag af regn­skabs­prin­cip­pet om fort­sat drift, med­min­dre le­del­sen en­ten har til hen­sigt at li­kvi­de­re sel­skabet, ind­stil­le drif­ten el­ler ik­ke har an­det re­a­lis­tisk al­ter­na­tiv end at gø­re det­te. Management is responsible for the preparation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act, and for such internal control as Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, Management is responsible for assessing the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting in preparing the financial statements unless Management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so. Vo­res mål er at op­nå høj grad af sik­ker­hed for, om års­regn­ska­bet som hel­hed er uden væ­sent­lig fejl­in­for­ma­tion, uan­set om den­ne skyl­des be­svi­gel­ser el­ler fejl, og at af­gi­ve en re­vi­si­ons­på­teg­ning med en kon­klu­si­on. Høj grad af sik­ker­hed er et højt ni­veau af sik­ker­hed, men er ik­ke en ga­ran­ti for, at en re­vi­si­on, der ud­fø­res i over­ens­stem­mel­se med in­ter­na­tio­na­le stan­dar­der om re­vi­si­on og de yder­li­ge­re krav, der er gæl­den­de i Dan­mark, al­tid vil af­dæk­ke væ­sent­lig fejl­in­for­ma­tion, når så­dan fin­des. Fejl­in­for­ma­tio­ner kan op­stå som føl­ge af be­svi­gel­ser el­ler fejl og kan be­trag­tes som væ­sent­li­ge, hvis det med ri­me­lig­hed kan for­ven­tes, at de en­kelt­vis el­ler sam­let har ind­fly­del­se på de øko­no­mis­ke be­slut­nin­ger, som regn­skabs­bru­ger­ne træf­fer på grund­lag af års­regn­ska­bet. Som led i en re­vi­si­on, der ud­fø­res i over­ens­stem­mel­se med in­ter­na­tio­na­le stan­dar­der om re­vi­si­on og de yder­li­ge­re krav, der er gæl­den­de i Dan­mark, fo­re­ta­ger vi fag­li­ge vur­de­rin­ger og op­ret­hol­der pro­fes­sio­nel skep­sis un­der re­vi­si­o­nen. Her­ud­over: Iden­ti­fi­ce­rer og vur­de­rer vi ri­si­ko­en for væ­sent­lig fejl­in­for­ma­tion i års­regn­ska­bet, uan­set om den­ne skyl­des be­svi­gel­ser el­ler fejl, ud­for­mer og ud­fø­rer re­vi­si­ons­hand­lin­ger som re­ak­tion på dis­se ri­si­ci samt op­når re­vi­si­ons­be­vis, der er til­stræk­ke­ligt og eg­net til at dan­ne grund­lag for vo­res kon­klu­sion. Ri­si­ko­en for ik­ke at op­da­ge væ­sent­lig fejl­in­for­ma­tion for­år­sa­get af be­svi­gel­ser er hø­je­re end ved væ­sent­lig fejl­in­for­ma­tion for­år­sa­get af fejl, idet be­svi­gel­ser kan om­fat­te sam­men­svær­gel­ser, do­ku­ment­falsk, be­vids­te ude­la­del­ser, vild­led­ning el­ler til­si­de­sæt­tel­se af in­tern kon­trol. Op­når vi for­stå­el­se af den in­ter­ne kon­trol med re­le­vans for re­vi­si­o­nen for at kun­ne ud­for­me re­vi­si­ons­hand­lin­ger, der er pas­sen­de ef­ter om­stæn­dig­he­der­ne, men ik­ke for at kun­ne ud­tryk­ke en kon­klu­sion om ef­fek­ti­vi­te­ten af sel­ska­bets in­ter­ne kon­trol. Ta­ger vi stil­ling til, om den regn­skabs­prak­sis, som er an­vendt af le­del­sen, er pas­sen­de, samt om de regn­skabs­mæs­si­ge skøn og til­knyt­te­de op­lys­nin­ger, som le­del­sen har ud­ar­bej­det, er ri­me­li­ge. Kon­klu­de­rer vi, om le­del­sens ud­ar­bej­del­se af års­regn­ska­bet på grund­lag af regn­skabs­prin­cip­pet om fort­sat drift er pas­sen­de, samt om der på grund­lag af det op­nå­e­de re­vi­si­ons­be­vis er væ­sent­lig usik­ker­hed for­bun­det med be­gi­ven­he­der el­ler for­hold, der kan ska­be be­ty­de­lig tvivl om sel­ska­bets ev­ne til at fort­sæt­te drif­ten. Hvis vi kon­klu­de­rer, at der er en væ­sent­lig usik­ker­hed, skal vi i vo­res re­vi­si­ons­på­teg­ning gø­re op­mærk­som på op­lys­nin­ger her­om i års­regn­ska­bet el­ler, hvis så­dan­ne op­lys­nin­ger ik­ke er til­stræk­ke­li­ge, mo­di­fi­ce­re vo­res kon­klu­si­on. Vo­res kon­klu­si­o­ner er ba­se­ret på det re­vi­si­ons­be­vis, der er op­nå­et frem til da­to­en for vo­res re­vi­si­ons­på­teg­ning. Frem­ti­di­ge be­gi­ven­he­der el­ler for­hold kan dog med­fø­re, at sel­skabet ik­ke læn­ge­re kan fort­sæt­te drif­ten. Ta­ger vi stil­ling til den sam­le­de præ­sen­ta­tion, struk­tur og ind­hold af års­regn­ska­bet, her­un­der no­te­op­lys­nin­ger­ne, samt om års­regn­ska­bet af­spej­ler de un­der­lig­gen­de trans­ak­tio­ner og be­gi­ven­he­der på en så­dan må­de, at der gi­ves et ret­vi­sen­de bil­le­de her­af. Plan­læg­ger og ud­fører vi revi­sionen af års­regn­ska­bet for at opnå til­stræk­ke­ligt og egnet revi­sions­bevis ved­rørende de kon­soli­derede finan­siel­le op­lys­ninger for virk­som­hederne eller for­ret­nings­en­hed­erne som grund­lag for at ud­forme en kon­klu­sion om års­regn­ska­bet. Vi er an­svar­lige for at lede, føre tilsyn med og gen­nem­gå det ud­førte revi­sions­ar­bej­de. Vi er ene­ansvar­lige for vores revi­sions­kon­klusion. Vi kom­mu­ni­ke­rer med den øver­ste le­del­se om blandt an­det det plan­lag­te om­fang og den tids­mæs­si­ge pla­ce­ring af re­vi­si­o­nen samt be­ty­de­li­ge re­vi­si­ons­mæs­si­ge ob­ser­va­tio­ner, her­un­der even­tu­el­le be­ty­de­li­ge mang­ler i in­tern kon­trol, som vi iden­ti­fi­ce­rer un­der re­vi­si­o­nen. Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs and the additional requirements applicable in Den­mark will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. As part of an audit conducted in accordance with ISAs and the additional requirements applicable in Den­mark, we exercise professional judgment and maintain professional skepticism throughout the audit. We also: Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by Management. Conclude on the appropriateness of Management’s use of the going concern basis of accounting in preparing the financial statements and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the Company to cease to continue as a going concern. Evaluate the overall presentation, structure and contents of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that gives a true and fair view. Plan and perform the audit of the financial statements to obtain sufficient appropriate audit evidence regarding consolidated financial information of the entities or business units as a basis for forming an opinion on the financial statements. We are responsible for the direction, supervision and review of the audit work performed. We remain solely responsible for our audit opinion.We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. Ud­tal­else om le­del­ses­be­ret­nin­genLe­del­sen er an­svar­lig for le­del­ses­be­ret­nin­gen. Vo­res kon­klu­sion om års­regn­ska­bet om­fat­ter ik­ke le­del­ses­be­ret­nin­gen, og vi ud­tryk­ker in­gen form for kon­klu­sion med sik­ker­hed om le­del­ses­be­ret­nin­gen. I til­knyt­ning til vo­res re­vi­si­on af års­regn­ska­bet er det vo­res an­svar at læ­se le­del­ses­be­ret­nin­gen og i den for­bin­del­se over­ve­je, om le­del­ses­be­ret­nin­gen er væ­sent­ligt in­kon­si­stent med års­regn­ska­bet el­ler vo­res vi­den op­nå­et ved re­vi­si­o­nen el­ler på an­den må­de sy­nes at in­de­hol­de væ­sent­lig fejl­in­for­ma­tion. Vo­res an­svar er der­ud­over at over­ve­je, om le­del­ses­be­ret­nin­gen in­de­hol­der kræ­ve­de op­lys­nin­ger i hen­hold til års­regn­skabs­lo­ven. Ba­se­ret på det ud­før­te ar­bej­de er det vo­res op­fat­tel­se, at le­del­ses­be­ret­nin­gen er i over­ens­stem­mel­se med års­regn­ska­bet og er ud­ar­bej­det i over­ens­stem­mel­se med års­regn­skabs­lo­vens krav. Vi har ik­ke fun­det væ­sent­lig fejl­in­for­ma­tion i le­del­ses­be­ret­nin­gen. Statement on Management’s ReviewManagement is responsible for Management’s Review. Our opinion on the financial statements does not cover Management’s Review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read Management’s Review and, in doing so, consider whether Management’s Review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether Management’s Review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that Management’s Review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of Management’s Review. Sel­skabets væsentligste aktiviteterHovedaktiviteten har i lighed med tidligere år bestået af, at drive virksomhed med bioteknologi og hermed forbundet virksomhed. Description of key activities of the companyLike previous years, the principal activities of the  Company are to operate in the biotechnology sector  and related activities. Usikkerhed ved indregning eller målingSelskabet er et udviklingsselskab, hvorfor der er en naturlig usikkerhed forbundet med måling af selskabets udviklingsaktiviteter og fremtidige indtjening. Selskabet har pr. 30. september 2025 indregnet 12.231 t.kr. vedrørende færdiggjorte udviklingsprojekter.  Værdien af udviklingsprojekterne afhænger af selskabets evne til at udvikle, markedsføre og sælge sine hovedprodukter Clinostars og Clinoreactors på et rentabelt niveau. Ledelsen vurderer, at selskabet vil implementere sine planer inden for en overskuelig fremtid. Selskabet er påbegyndt arbejdet på den videre plan i efterfølgende regnskabsår, hvorfor ledelsen anser værdiansættelsen for rimelig. Hvis selskabets salg og vækst afviger væsentligt fra de nuværende planer, kan der være usikkerhed forbundet med værdiansættelsen. Der henvises til note 2 for yderligere omtale heraf. Uncertainties about recognition or measurementThe Company is a development-stage company, and there is therefore inherent uncertainty associated with the measurement of the Company’s development activities and future earnings. As at 30 September 2025, the Company has recognised t.DKK 12,231 in respect of completed development projects. The value of the development projects depends on the Company’s ability to develop, market and sell its main products, Clinostars and Clinoreactors, at a profitable level. Management assesses that the Company will implement its plans within a foreseeable future. Work on the subsequent phase of the plan has been initiated in the following financial year, and management therefore considers the valuation to be reasonable. If the Company’s sales and growth deviate significantly from the current plans, there may be uncertainty associated with the valuation. Reference is made to note 2 for further information. Væsentlige ændringer i virksomhedens aktiviteter og økonomiske forholdDer har ikke været væsent­lige æn­dring­er i ak­tivi­teter og øko­no­miske for­hold. Årets bruttofortjeneste ud­gør -7.875 t.kr. mod 1.463 t.kr. sid­ste år. Det or­di­næ­re re­sul­tat ef­ter skat ud­gør -45.568 t.kr. mod -20.899 t.kr. sid­ste år. Le­del­sen an­ser årets re­sul­tat som forventet.  KapitalberedskabSelskabet har tabt selskabskapitalen og er derfor omfattet af Selskabslovens bestemmelser om kapitaltab. Selskabet har igangværende udviklingsprojekter, der forventes at kunne bidrage med indtjening, der kan reetablere selskabskapitalen Selskabet har i november 2025 modtaget 20 mDKK fra en investor i overensstemmelse med tidligere indgået aftale og som oplyst i årsrapporten for 2023/24. Selskabet fortsætter samtidig sin kapitalsøgning med henblik på at tiltrække ny kapital til den forsatte udvikling. Det er ledelsens forventning, at disse forhandlinger vil være afsluttet inden 30. juni 2026. Forventningen er naturligt behæftet med almindelig usikkerhed, men ledelsen har planer for tiltag, så det nuværende likviditetsberedskab kan udstrækkes til en længere periode, såfremt kapitalrejsningen forsinkes.  Selskabets hovedanpartshavere har endvidere bekræftet, at anfordringslån ikke kræves indfriet i det kommende regnskabsår, ligesom der er opnået tilsagn om at opretholde nuværende lånefaciliteter. Ledelsen har således tillid til selskabets evne til at fortsætte driften, hvorfor regnskabet på den baggrund er udarbejdet under forudsætning af fortsat drift. Der henvises til note 1 for yderligere omtale heraf. Significant changes in the company's activities and financial mattersThere have been no significant changes in activities and financial matters. The gross profit for the year totals t.DKK -7,875  against t.DKK 1,463 last year. Income or loss  from ordinary activities after tax totals t.DKK  -45,568 against t.DKK -20,899 last year.  Management considers the net profit or loss for the year as expected. Financial resourcesThe Company has lost its share capital and is therefore subject to the provisions of the Danish Companies Act regarding capital loss. The Company has ongoing development projects that are expected to generate earnings capable of restoring the share capital. In November 2025, the Company received DKK 20 million from an investor in accordance with a previously entered agreement, as disclosed in the annual report for 2023/24. At the same time, the Company continues its capital-raising activities with a view to attracting new capital for its continued development. Management expects that these negotiations will be concluded before 30 June 2026. This expectation is naturally subject to ordinary uncertainty; however, management has plans for measures that will allow the current liquidity preparedness to be extended for a longer period should the capital raising be delayed. The Company’s principal shareholders have furthermore confirmed that shareholder loans repayable on demand will not be required to be repaid in the coming financial year, and commitments have also been obtained to maintain the existing credit facilities. Management therefore has confidence in the Company’s ability to continue its operations, and the financial statements have accordingly been prepared on a going concern basis. Reference is made to note 1 for further information. 1.KapitalforholdFinancial resourcesSelskabet har tabt selskabskapitalen og er derfor omfattet af Selskabslovens bestemmelser om kapitaltab. Selskabet har igangværende udviklingsprojekter, der forventes at kunne bidrage med indtjening, der kan reetablere selskabskapitalen.The Company has lost its share capital and is therefore subject to the provisions of the Danish Companies Act regarding capital loss. The Company has ongoing development projects that are expected to generate earnings capable of restoring the share capital. Selskabet har i november 2025 modtaget 20 mDKK fra en investor i overensstemmelse med tidligere indgået aftale og som oplyst i årsrapporten for 2023/24. Selskabet fortsætter samtidig sin kapitalsøgning med henblik på at tiltrække ny kapital til den forsatte udvikling. Det er ledelsens forventning, at disse forhandlinger vil være afsluttet inden 30. juni 2026. Forventningen er naturligt behæftet med almindelig usikkerhed, men ledelsen har planer for tiltag, så det nuværende likviditetsberedskab kan udstrækkes til en længere periode, såfremt kapitalrejsningen forsinkes.  In November 2025, the Company received DKK 20 million from an investor in accordance with a previously entered agreement, as disclosed in the annual report for 2023/24. At the same time, the Company continues its capital-raising activities with a view to attracting new capital for its continued development. Management expects that these negotiations will be concluded before 30 June 2026. This expectation is naturally subject to ordinary uncertainty; however, management has plans for measures that will allow the current liquidity preparedness to be extended for a longer period in the event that the capital raising is delayed. Selskabets hovedanpartshavere har endvidere bekræftet, at anfordringslån ikke kræves indfriet i det kommende regnskabsår ligesom, der er der opnået tilsagn om at opretholde nuværende lånefaciliteter. The Company’s principal shareholders have furthermore confirmed that shareholder loans repayable on demand will not be required to be repaid in the coming financial year, and commitments have also been obtained to maintain the existing credit facilities. Ledelsen har således tillid til selskabets evne til at fortsætte driften, hvorfor regnskabet på den baggrund er udarbejdet under forudsætning af fortsat drift. Management therefore has confidence in the Company’s ability to continue its operations, and the financial statements have accordingly been prepared on a going concern basis. 2.Usikkerhed ved indregning eller målingUncertainties concerning recognition and measurementSelskabet er et udviklingsselskab, hvorfor der er en naturlig usikkerhed forbundet med måling af selskabets udviklingsaktiviteter og fremtidige indtjening. Selskabet har pr. 30. september 2025 indregnet 12.231 t.kr. vedrørende færdiggjorte udviklingsprojekter.  The Company is a development-stage company, and there is therefore inherent uncertainty associated with the measurement of the Company’s development activities and future earnings. As at 30 September 2025, the Company has recognised t.DKK 12,231  in respect of completed development projects. Værdien af udviklingsprojekterne afhænger af selskabets evne til at udvikle, markedsføre og sælge sine hovedprodukter Clinostars og Clinoreactors på et rentabelt niveau. The value of the development projects depends on the Company’s ability to develop, market and sell its main products, Clinostars and Clinoreactors, at a profitable level. Ledelsen vurderer, at selskabet vil implementere sine planer inden for en overskuelig fremtid. Selskabet er påbegyndt arbejdet på den videre plan i efterfølgende regnskabsår, hvorfor ledelsen anser værdiansættelsen for rimelig. Hvis selskabets salg og vækst afviger væsentligt fra de nuværende planer, kan der være usikkerhed forbundet med værdiansættelsen.Management assesses that the Company will implement its plans within a foreseeable future. Work on the subsequent phase of the plan has been initiated in the following financial year, and management therefore considers the valuation to be reasonable. If the Company’s sales and growth deviate significantly from the current plans, there may be uncertainty associated with the valuation. 12.Kontraktlige forpligtelser og eventualposter m.v.Contractual obligations and contingencies, etc.EventualaktiverContingent assetsSelskabet har skattemæssigt underskud til fremførsel. Skatteværdien af det skattemæssige underskud til fremførsel udgør ca. t.DKK 23.200, beregnet til en sats på 22%, hvilket ikke er indregnet i balancen, da det der usikkert, hvornår underskuddet kan udnyttes.The Company has tax losses carried forward. The tax value of the tax losses carried forward amounts to approximately t.DKK 23,200, calculated at a tax rate of 22%, which has not been recognised in the statement of financial position, as there is uncertainty as to when the losses can be utilised. Kontraktlige forpligtelser og eventualforpligtelserContractual obligations and contingent liabilities t.kr. DKK in thousands Andre kontraktlige forpligtelserOther contractual obligations2.232 Kontraktlige forpligtelser i altTotal contractual obligations2.232 Kontraktlige forpligtelser og eventualforpligtelser i altTotal contractual obligations and contingent liabilities2.232 Års­rap­por­ten for Celvivo ApS er af­lagt i over­ens­stem­mel­se med års­regn­skabs­lo­vens be­stem­mel­ser for en klasse B-virksomhed. Her­ud­over har virk­som­he­den valgt at føl­ge en­kel­te reg­ler for klas­se C-virk­som­he­der. Års­rap­porten er af­lagt ef­ter sam­me regn­skabs­prak­sis som sid­ste år og aflægges i danske kroner. The annual report for Celvivo ApS has been presented in accordance with the Danish Financial Statements Act regulations concerning reporting class B enterprises. Furthermore, the company has decided to comply with certain rules applying to reporting class C enterprises. The accounting policies are unchanged from last year, and the annual report is presented in DKK. Generelt om indregning og målingI re­sul­tat­op­gø­rel­sen ind­reg­nes ind­tæg­ter i takt med, at de ind­tje­nes. Her­un­der ind­reg­nes vær­di­re­gu­le­rin­ger af fi­nan­siel­le ak­ti­ver og for­plig­tel­ser. I re­sul­tat­op­gø­rel­sen ind­reg­nes li­ge­le­des al­le om­kost­nin­ger, her­un­der af­skriv­nin­ger, ned­skriv­nin­ger og hen­sat­te for­plig­tel­ser samt til­ba­ge­førs­ler som føl­ge af æn­dre­de regn­skabs­mæs­si­ge skøn af be­løb, der tid­li­ge­re har væ­ret ind­reg­net i re­sul­tat­op­gø­rel­sen. Ak­ti­ver ind­reg­nes i ba­lan­cen, når det er sand­synligt, at frem­ti­di­ge øko­no­mi­ske for­de­le vil til­fly­de sel­skabet, og ak­ti­vets vær­di kan må­les på­li­de­ligt. For­plig­tel­ser ind­reg­nes i ba­lan­cen, når det er sandsyn­ligt, at frem­ti­di­ge øko­no­mi­ske for­de­le vil fra­gå sel­skabet, og for­plig­tel­sens vær­di kan må­les på­li­de­ligt. Ved før­ste ind­reg­ning må­les ak­ti­ver og for­plig­telser til kost­pris. Ef­ter­føl­gen­de må­les ak­ti­ver og for­plig­tel­ser som be­skre­vet ne­den­for for hver en­kelt regn­skabs­post. Ved ind­reg­ning og må­ling ta­ges hen­syn til for­ud­sige­li­ge tab og ri­si­ci, der frem­kom­mer in­den års­rap­por­ten af­læg­ges, og som ved­rø­rer for­hold, der ek­si­ste­re­de på ba­lan­ce­da­gen. Recognition and measurement in generalIncome is recognised in the income statement concurrently with its realisation, including the recognition of value adjustments of financial assets and liabilities. Likewise, all costs are recognised in the income statement, including depreciations amortisations, writedowns for impairment, provisions, and reversals due to changes in estimated amounts previously recognised in the income statement. Assets are recognised in the statement of financial position when it seems probable that future economic benefits will flow to the company and the value of the asset can be reliably measured. Liabilities are recognised in the statement of financial position when it is seems probable that future economic benefits will flow out of the company and the value of the liability can be reliably measured. Assets and liabilities are measured at cost at the initial recognition. Hereafter, assets and liabilities are measured as described below for each individual accounting item. Upon recognition and measurement, allowances are made for such predictable losses and risks which may arise prior to the presentation of the annual report and concern matters that exist on the reporting date. Omregning af fremmed valutaTrans­ak­tio­ner i frem­med va­lu­ta om­reg­nes til trans­ak­tions­da­gens kurs. Va­lu­ta­kurs­dif­fe­ren­cer, der op­står mel­lem trans­ak­tions­da­gens kurs og kur­sen på be­ta­lings­da­gen, ind­reg­nes i re­sul­tat­op­gø­rel­sen som en fi­nan­siel post. Hvis va­lu­ta­po­si­tio­ner an­ses for sik­ring af frem­ti­di­ge pen­ge­strøm­me, ind­reg­nes vær­di­re­gu­le­rin­ger­ne di­rek­te på egen­ka­pi­ta­len i en dags­vær­di­re­ser­ve. Til­go­de­ha­ven­der, gæld og an­dre mo­ne­tæ­re pos­ter i frem­med va­lu­ta, om­reg­nes til ba­lan­ce­da­gens va­lu­ta­kurs. For­skel­len mel­lem ba­lan­ce­da­gens kurs og kur­sen på tids­punk­tet for til­go­de­ha­ven­dets el­ler gælds­for­plig­tel­sens op­stå­en el­ler ind­reg­ning i se­ne­ste års­regn­skab ind­reg­nes i re­sul­tat­op­gø­rel­sen un­der fi­nan­siel­le ind­tæg­ter og om­kost­nin­ger. An­lægs­ak­ti­ver, der er købt i frem­med va­lu­ta må­les til kur­sen på trans­ak­tions­da­gen. Uden­land­ske til­knyt­te­de virk­som­he­der, as­so­ci­e­re­de virk­som­he­der og ka­pi­tal­in­te­res­ser an­ses for at være selv­stæn­di­ge en­he­der. Re­sul­tat­op­gø­rel­ser­ne om­reg­nes til en gen­nem­snit­lig va­lu­ta­kurs for må­ne­den, og ba­lan­ce­pos­ter­ne om­reg­nes til ba­lan­ce­da­gens va­lu­ta­kur­ser. Kurs­dif­fe­ren­cer, op­stå­et ved om­reg­ning af uden­land­ske til­knyt­te­de virk­som­he­ders egen­ka­pi­tal ved årets be­gyn­del­se til ba­lan­ce­da­gens va­lu­ta­kur­ser og ved om­reg­ning af re­sul­tat­op­gø­rel­ser fra gen­nem­snits­kur­ser til ba­lan­ce­da­gens va­lu­ta­kur­ser, ind­reg­nes di­rek­te i egen­ka­pi­ta­len i dags­vær­di­re­ser­ven i kon­cern­regn­ska­bet. Dette gæl­der og­så kurs­dif­fe­ren­cer, som er op­stå­et ved om­reg­­ning af re­sul­tat­op­gø­rel­ser fra gen­nem­snits­kur­ser til ba­lan­ce­da­gens va­lu­ta­kur­ser. Kurs­re­gu­le­ring af mel­lem­væ­ren­der med uden­land­ske til­knyt­te­de virk­som­he­der, der an­ses for en del af den sam­le­de in­ve­ste­ring i til­knyt­te­de virk­som­he­der, ind­reg­nes di­rek­te i egen­ka­pi­ta­len i dags­vær­di­re­ser­ven. Til­sva­ren­de ind­reg­nes va­lu­ta­kurs­ge­vin­ster og va­lu­ta­kurs­tab på lån og af­led­te fi­nan­siel­le in­stru­men­ter, som er ind­gå­et til kurs­sik­ring af selv­stæn­di­ge uden­land­ske til­knyt­te­de virk­som­he­der, di­rek­te i egen­ka­pi­ta­len. Ved ind­reg­ning af uden­land­ske til­knyt­te­de virk­som­he­der, der er in­te­gre­re­de en­he­der, om­reg­nes mo­ne­tæ­re pos­ter til ba­lan­ce­da­gens kurs. Ikke-mo­ne­tæ­re pos­ter om­reg­nes til kur­sen på an­skaf­fel­ses­tids­punk­tet el­ler på tids­punk­tet for ef­ter­føl­gen­de op- eller ned­skriv­ning af ak­ti­vet. Re­sul­tat­op­gø­rel­sens po­ster om­reg­nes til trans­ak­tions­da­gens kurs, idet pos­ter af­ledt af ikke-mo­ne­tæ­re pos­ter dog om­reg­nes til hi­sto­ri­ske kur­ser for den ikke-mo­ne­tæ­re post. Foreign currency translationTransactions in foreign currency are translated by using the exchange rate prevailing at the date of the transaction. Differences in the rate of exchange arising between the rate at the date of transaction and the rate at the date of payment are recognised in the profit and loss account as an item under net financials. If currency positions are considered to hedge future cash flows, the value adjustments are recognised directly in equity in a fair value reserve. Receivables, payables, and other foreign currency monetary items are translated using the closing rate. The difference between the closing rate and the rate at the time of the occurrence or initial recognition in the latest financial statements of the receivable or payable is recognised in the income statement under financial income and expenses. Fixed assets acquired and paid for in foreign currency are measured at the exchange rate prevailing at the date of  the transaction. Group enterprises abroad, associates, and equity investments are considered to be independent entities. The income statements are translated at an average exchange rate for the month, and the balance sheet items are translated at the closing rates. Currency translation differences, arising from the translation of the equity of group enterprises abroad at the beginning of the year to the closing rate and from the translation of income statements from average prices to the closing rate, are recognised directly in equity in the fair value reserve in the Consolidated Financial Statement. This also applies to differences arising from translation of income statements from average exchange rate to closing rate. Translation adjustment of balances with group enterprises abroad that are considered part of the total investment in group enterprises are recognised directly in equity in the fair value reserve. Likewise, foreign exchange gains and losses on loans and derived financial instruments for currency hedging independent group enterprises abroad are recognised directly in equity. When recognising foreign group enterprises which are integral units, the monetary items are translated using the closing rate. Non-monetary items are translated using the exchange rate prevailing at the time of acquisition or at the time of the subsequent revaluation or write-down for impairment of the asset. Income statement items are translated using the exchange rate prevailing at the date of the transaction. However, items in the income statement derived from non-monetary items are translated using historical prices. BruttotabBruttotab in­de­hol­der net­to­om­sæt­ning, æn­dring i lag­re af fær­dig­va­rer og va­rer un­der frem­stil­ling, ar­bej­de ud­ført for egen reg­ning og op­ført un­der ak­ti­ver, an­dre drifts­ind­tæg­ter samt eks­ter­ne om­kost­nin­ger. Net­to­om­sæt­ning ind­reg­nes i re­sul­tat­op­gø­rel­sen, så­fremt le­ve­ring og ri­si­ko­over­gang til kø­ber har fun­det sted in­den årets ud­gang, og så­fremt ind­tæg­ten kan op­gø­res på­li­de­ligt og for­ven­tes mod­ta­get. Net­to­om­sæt­nin­gen må­les til dags­vær­dien af det af­tal­te ve­der­lag eks­klu­si­ve moms og af­gif­ter og med fra­drag af ra­bat­ter i for­bin­del­se med sal­get. Gross lossGross loss comprises the revenue, changes in inventories of finished goods, and work in progress, own work capitalised, other operating income, and external costs. Revenue is recognised in the income statement if delivery and passing of risk to the buyer have taken place before the end of the year and if the income can be determined reliably and inflow is anticipated. Revenue is measured at the fair value of the consideration promised exclusive of VAT and taxes and less any discounts relating directly to sales. Va­re­for­brug om­fat­ter om­kost­nin­ger til køb af rå­varer og hjæl­pe­ma­te­ri­a­ler med fra­drag af ra­bat­ter samt årets for­skyd­ning i va­re­be­hold­nin­ger. Cost of sales comprises costs concerning purchase of raw materials and consumables less discounts and changes in inventories. Arbejde udført for egen reg­ning og op­ført under ak­ti­verArbejde udført for egen reg­ning og op­ført un­der ak­ti­ver om­fat­ter per­so­na­le­om­kost­nin­ger og an­dre in­ter­ne om­kost­nin­ger, der er af­holdt i regn­skabs­året og ind­reg­net i kost­pri­sen for egen­ud­vik­le­de im­ma­te­ri­el­le og ma­te­ri­el­le an­lægs­ak­ti­ver. Work performed for own account and capitalisedWork performed for own account and capitalised includes staff cost and other internal costs incurred during the financial year and recognised in the cost of proprietary intangible and tangible fixed assets. Andre drifts­ind­tæg­ter inde­hol­der regn­skabs­pos­ter af se­kun­dær ka­rak­ter i for­hold til virk­som­he­dens ho­ved­ak­ti­vi­te­ter.   Other operating income comprises items of a secondary nature as regards the principal activities of the enterprise. Offentlige tilskudTilskud til investering/indkøb af aktiverTilskud indregnes i ba­lan­cen un­der pe­rio­de­af­græns­nings­pos­ter (pas­si­ver) og over­fø­res til of­fent­li­ge til­skud i re­sul­tat­op­gø­rel­sen i takt med af­skriv­ning af de ak­ti­ver, til­skud­de­ne ved­rø­rer. Government grantsGrants for investing in/purchasing assetsGrants are recognised in the statement of financial position under prepayments and accrued income (equity and liabilities) and transferred to government grants in the income statement in tandem with the amortisation of the grant-related assets. Andre eks­ter­ne om­kost­nin­ger om­fat­ter om­kost­nin­ger til salg, re­kla­me, ad­mi­ni­stra­tion og  loka­ler. Other external expenses comprise expenses incurred for distribution, sales, advertising, administration and premises. PersonaleomkostningerPer­so­na­le­om­kost­nin­ger om­fat­ter løn og ga­ger, in­klu­si­ve fe­rie­pen­ge og pen­sio­ner samt an­dre om­kost­nin­ger til so­ci­al sik­ring mv. til sel­skabets med­ar­bej­de­re. Staff costsStaff costs include salaries and wages, including holiday allowances, pensions, and other social security costs, etc., for staff members. Af- og nedskrivningerAf- og ned­skriv­nin­ger in­de­hol­der årets af- og ned­skriv­nin­ger samt for­tje­ne­ste og tab ved salg af im­ma­te­ri­el­le og ma­te­ri­el­le an­lægs­ak­ti­ver. Depreciation, amortisation, and writedown for impairmentDepreciation, amortisation, and writedown for impairment comprise depreciation, amortisation, and writedown for the year and profit and loss on the disposal of intangible and tangible assets. Indtægter af ka­pi­tal­an­de­le i tilknyttede virksomhederI re­sul­tat­op­gø­rel­sen ind­reg­nes den for­holds­mæs­si­ge an­del af de en­kel­te til­knyt­te­de virk­som­he­ders re­sul­tat ef­ter skat ef­ter fuld e­li­mi­ne­ring af in­tern avan­ce el­ler tab og fra­drag af af­skriv­ning på good­will og til­læg af ne­ga­tiv good­will. Results from investments in group enterprisesAfter full elimination of intercompany profit or loss less amortised consolidated goodwill, the investment in the individual entities are recognised in the income statement as a proportional share of the entities' post-tax profit or loss. Finansielle indtægter og omkostningerFi­nan­siel­le ind­tæg­ter og om­kost­nin­ger ind­reg­nes i re­sul­tat­op­gø­rel­sen med de be­løb, der ved­rø­rer regn­skabs­året. Fi­nan­siel­le pos­ter om­fat­ter ren­te­ind­tæg­ter og -om­kost­nin­ger og re­a­li­se­re­de og u­re­a­li­se­re­de kurs­ge­vin­ster og kurs­tab ved­rø­ren­de trans­ak­tio­ner i frem­med va­lu­ta.  Financial income and expensesFinancial income and expenses are recognised in the income statement with the amounts concerning the financial year. Financial income and expenses comprise interest income and expenses and realised and unrealised capital gains and losses relating to transactions in foreign currency. Skat af årets resultatÅrets skat, der be­står af årets ak­tu­el­le sel­skabs­skat og æn­dring i ud­skudt skat, ind­reg­nes i re­sul­tat­op­gø­rel­sen med den del, der kan hen­fø­res til årets re­sul­tat, og di­rek­te i eg­en­ka­pi­ta­len med den del, der kan hen­fø­res til po­ste­rin­ger di­rek­te i eg­en­ka­pi­ta­len.  Tax on net profit or loss for the yearTax for the year comprises the current income tax for the year and changes in deferred tax and is recognised in the income statement with the share attributable to the net profit or loss for the year and directly in equity with the share attributable to entries directly in equity.  Immaterielle anlægsaktiverUdviklingsprojekter, patenter og licenserUd­vik­lings­om­kost­nin­ger og in­ternt op­ar­bej­de­de ret­tig­he­der ind­reg­nes i re­sul­tat­op­gø­rel­sen som om­kost­nin­ger i an­skaf­fel­ses­å­ret. Pa­ten­ter og li­cen­ser må­les til kost­pris med fra­drag af ak­ku­mu­le­re­de af- og ned­skriv­nin­ger. Pa­ten­ter af­skri­ves li­ne­ært ov­er den re­ste­ren­de pa­tent­pe­ri­o­de, og li­cen­ser af­skri­ves over af­ta­le­pe­ri­o­den, dog mak­si­malt 10 år. For­tje­ne­ste og tab ved salg af ud­vik­lings­pro­jek­ter, pa­ten­ter og li­cen­ser op­gø­res som for­skel­len mel­lem salgs­pri­sen med fra­drag af salgs­om­kost­nin­ger og den regn­skabs­mæs­si­ge vær­di på salgs­tids­punk­tet. For­tje­ne­ste el­ler tab ind­reg­nes i re­sul­tat­op­gø­rel­sen un­der af- og ned­skriv­nin­ger. Intangible assetsDevelopment projects, patents, and licencesDevelopment costs and internally generated rights are recognised in the income statement as costs in the acquisition year. Patents and licenses are measured at cost less accrued amortisation. Patents are amortised on a straightline basis over the remaining patent period and licenses are amortised over the contract period, however, for a maximum of 10 years. Profit and loss from the sale of development projects, patents, and licenses are measured as the difference between the sales price less sales costs and the carrying amount at the time of sale. Profit or loss is recognised in the income statement under amortisation and write-down for impairment. Materielle anlægsaktiverMaterielle anlægsaktiver må­les til kost­pris med fra­drag af ak­ku­mu­le­re­de af­skriv­nin­ger og ned­skriv­nin­ger. Der af­skri­ves ik­ke på grun­de. Af­skriv­nings­grund­la­get er kost­pris med fra­drag af even­tu­el for­ven­tet rest­vær­di ef­ter af­slut­tet brugs­tid. Af­skriv­nings­pe­ri­o­den og rest­vær­di­en fast­sæt­tes på an­skaf­fel­ses­tids­punk­tet og re­vur­de­res år­ligt. Over­sti­ger rest­vær­di­en ak­ti­vets regn­skabs­mæs­si­ge vær­di, op­hø­rer af­skriv­nin­gen. Der fo­re­ta­ges li­ne­ære af­skriv­nin­ger ba­se­ret på føl­gen­de vur­de­ring af ak­ti­ver­nes for­ven­te­de brugs­ti­der og rest­vær­di­er: BrugstidRestværdiAndre anlæg, driftsmateriel og inventar5år0 % Småaktiver med en forventet levetid under 1 år ind­reg­nes i an­skaf­fel­ses­året som om­kost­nin­ger i re­sul­tat­op­gø­rel­sen. For­tje­ne­ste el­ler tab ved af­hæn­del­se af ma­te­ri­el­le an­lægs­ak­ti­ver op­gø­res som for­skel­len mel­lem salgs­pris med fra­drag af salgs­om­kost­nin­ger og den regn­skabs­mæs­si­ge vær­di på salgs­tids­punk­tet. For­tje­ne­ste el­ler tab ind­reg­nes i re­sul­tat­op­gø­rel­sen un­der af- og ned­skriv­nin­ger. Property, plant, and equipmentProperty, plant, and equipment are measured at cost less accrued depreciation and write-down for impairment. Land is not subject to depreciation. The depreciable amount is cost less any expected residual value after the end of the useful life of the asset. The amortisation period and the residual value are determined at the acquisition date and reassessed annually. If the residual value exceeds the carrying amount, the depreciation is discontinued. Depreciation is done on a straight-line basis according to an assessment of the expected useful life and the residual value of the individual assets:   ResidualUseful lifevalueOther fixtures and fittings,tools and equipment5years0 % Minor assets with an expected useful life of less than 1 year are recognised as costs in the income statement in the year of acquisition. Profit or loss derived from the disposal of property, land, and equipment is measured as the difference between the sales price less selling costs and the carrying amount at the date of disposal. Profit or loss is recognised in the income statement under depreciation. Indretning af lejede lokalerInd­ret­ning af le­je­de lo­ka­ler må­les til kost­pris med fra­drag af ak­ku­mu­le­re­de af­skriv­nin­ger. Der fo­re­tages li­ne­æ­re af­skriv­nin­ger ba­se­ret på vur­de­ring af ak­ti­vets for­ven­te­de brugs­tid, der er sat til 5 år. Leasehold improvementsLeasehold improvements are measured at cost less accrued depreciations. Depreciation is done on a straightline basis over the estimated useful life of the asset, which is set at 5 years. Ka­pi­tal­an­de­le i tilknyttede virksomhederKa­pi­tal­an­de­le i tilknyttede virksomheder ind­reg­nes og må­les ef­ter den in­dre vær­dis me­to­de. In­dre vær­dis me­to­de an­ven­des som en konsolideringsmetode. I ba­lan­cen ind­reg­nes ka­pi­tal­an­de­le i tilknyttede virksomheder til den for­holds­mæs­si­ge an­del af virk­som­he­dens regn­skabs­mæs­si­ge in­dre vær­di. Den­ne op­gø­res ef­ter mo­der­virk­som­he­dens regn­skabs­prak­sis med fra­drag el­ler til­læg af u­re­a­li­se­re­de kon­cern­in­ter­ne avan­cer og tab samt med til­læg el­ler fra­drag af re­ste­ren­de vær­di af po­si­tiv el­ler ne­ga­tiv go­od­will op­gjort ef­ter over­ta­gel­ses­me­to­den. Ne­ga­tiv good­will ind­reg­nes i re­sul­tat­op­gø­rel­sen ved kø­bet af ka­pi­tal­an­de­len. Ved­rø­rer den ne­ga­ti­ve good­will over­tag­ne even­tu­al­for­plig­tel­ser, ind­tægts­fø­res ne­ga­tiv good­will først, når even­tu­al­for­plig­tel­ser­ne er af­vik­let el­ler bort­fal­det. For væ­sent­li­ge ak­ti­ver og for­plig­tel­ser, der er ind­reg­net i tilknyttede virksomheder, men ikke fin­des i mo­der­virk­som­he­den, er føl­gen­de regn­skabs­praksis an­vendt: Ka­pi­tal­an­de­le i tilknyttede virksomheder med regn­skabs­mæs­sig ne­ga­tiv in­dre vær­di må­les til 0 kr., og et even­tu­elt til­go­de­ha­ven­de hos dis­se virk­som­he­der ned­skri­ves, i det om­fang til­go­de­ha­ven­det er uer­hol­de­ligt. I det om­fang mo­der­virk­som­he­den har en ret­lig el­ler fak­tisk for­plig­tel­se til at dæk­ke en un­der­ba­lan­ce, der over­sti­ger til­go­de­ha­ven­det, ind­reg­nes det re­ste­ren­de be­løb un­der hen­sat­te for­plig­tel­ser. Net­to­op­skriv­ning af ka­pi­tal­an­de­le i tilknyttede virksomheder over­fø­res un­der egen­ka­pi­ta­len til re­ser­ve for net­to­op­skriv­ning ef­ter den in­dre vær­dis me­to­de i det om­fang, den regn­skabs­mæs­si­ge vær­di over­sti­ger kost­prisen. Udbytter fra tilknyttede virksomheder, der for­ven­tes ved­ta­get in­den god­ken­del­sen af nær­væ­ren­de års­rap­port, bin­des ik­ke på op­skriv­nings­re­ser­ven. Re­ser­ven re­gu­le­res med an­dre egen­ka­pi­tal­be­væ­gel­ser i tilknyttede virksomheder. Ny­er­hver­ve­de el­ler ny­stif­te­de virk­som­he­der ind­reg­nes i års­regn­ska­bet fra an­skaf­fel­ses­tids­punk­tet. Solg­te el­ler af­vik­le­de virk­som­he­der ind­reg­nes frem til af­stå­el­ses­tids­punk­tet. Ved køb af virk­som­he­der an­ven­des over­ta­gel­ses­me­to­den, sam­men­læg­nings­me­to­den el­ler bog­ført vær­di me­to­den, jf. be­skri­vel­se oven­for un­der Virk­som­heds­sam­men­slut­nin­ger. Investments in group enterprisesInvestments in group enterprises are recognised and measured by applying the equity method. The equity method is used as a method of consolidation. Investments in group enterprises are recognised in the statement of financial position at the proportionate share of the enterprise's equity value. This value is calculated in accordance with the parent's accounting policies with deductions or additions of unrealised intercompany gains and losses as well as with additions or deductions of the remaining value of positive or negative goodwill calculated in accordance with the acquisition method. Negative goodwill is recognised in the income statement at the time of acquisition of the equity investment. If the negative goodwill relates to contingent liabilities acquired, negative goodwill is not recognised until the contingent liabilities have been settled or lapsed. In relation to material assets and liabilities recognised in group enterprises but are not represented in the parent, the following accounting policies have been applied. Investments in group enterprises with a negative equity value are measured at DKK 0, and any accounts receivable from these enterprises are written down to the extent that the account receivable is uncollectible. To the extent that the parent has a legal or constructive obligation to cover an negative balance that exceeds the account receivable, the remaining amount is recognised under provisions. To the extent the equity exceeds the cost, the net revaluation of equity investments in group enterprises  transferred to the reserve under equity for net revaluation according to the equity method. Dividends from group enterprises expected to be adopted before the approval of this annual report are not subject to a limitation of the revaluation reserve. The reserve is adjusted by other equity movements in group enterprises. Newly acquired or newly established companies are recognised in the financial statement as of the time of acquisition. Sold or liquidated companies are recognised until the date of disposal. On the acquisition of enterprises, the acquisition method, the uniting-of-interests method or the book value method is applied, cf. the above description under Business combinations. DepositaDeposita måles til amortiseret kostpris og udgøres af huslejedeposita mv. DepositsDeposits are measured at amortised cost and represent lease deposits, etc. Nedskrivning på anlægsaktiverDen regn­skabs­mæs­si­ge vær­di af så­vel im­ma­te­ri­el­le som ma­te­ri­el­le an­lægs­ak­ti­ver samt ka­pi­tal­an­de­le i tilknyttede virksomheder vur­de­res år­ligt for in­dika­tio­ner på vær­di­for­rin­gel­se ud over det, som ud­tryk­kes ved af­skriv­ning. Fo­re­lig­ger der in­di­ka­tio­ner på vær­di­for­rin­gel­se, fo­re­ta­ges ned­skriv­nings­test af hvert en­kelt ak­tiv hen­holds­vis grup­pe af ak­ti­ver. Der fo­re­ta­ges ned­skriv­ning til gen­ind­vin­dings­vær­di­en, så­fremt den­ne er la­ve­re end den regn­skabs­mæs­si­ge vær­di. Gen­ind­vin­dings­vær­di­en er den hø­je­ste vær­di af ka­pi­tal­vær­di og salgs­vær­di fra­truk­ket for­ven­te­de om­kost­nin­ger ved et salg. Ka­pi­tal­vær­di­en op­gø­res som nu­tids­vær­di­en af de for­ven­te­de net­to­pen­ge­strøm­me fra an­ven­del­sen af ak­ti­vet el­ler ak­tiv­grup­pen og for­ven­te­de net­to­pen­ge­strøm­me ved salg af ak­ti­vet el­ler ak­tiv­grup­pen ef­ter endt brugs­tid. Tid­li­ge­re ind­reg­ne­de ned­skriv­nin­ger til­ba­ge­fø­res, når be­tin­gel­sen for ned­skriv­nin­gen ik­ke læn­ge­re be­står.  Impairment loss relating to non-current assetsThe carrying amount of both intangible and tangible fixed assets as well as equity investments in group enterprises are subject to annual impairment tests in order to disclose any indications of impairment beyond those expressed by amortisation and depreciation respectively. If indications of impairment are disclosed, impairment tests are carried out for each individual asset or group of assets, respectively. Writedown for impairment is done to the recoverable amount if this value is lower than the carrying amount. The recoverable amount is the higher value of value in use and selling price less expected selling cost. The value in use is calculated as the present value of the expected net cash flows from the use of the asset or the asset group and expected net cash flows from the sale of the asset or the asset group after the end of their useful life. Previously recognised impairment losses are reversed when conditions for impairment no longer exist.  VarebeholdningerVa­re­be­hold­nin­ger må­les til kost­pris ef­ter FIFO-me­to­den. Er net­to­re­a­li­sa­tions­vær­di­en af va­re­be­hold­nin­ger la­ve­re end kost­pri­sen, ned­skri­ves til den­ne la­ve­re vær­di. Kost­pris for han­dels­va­rer samt rå­va­rer og hjæl­pe­ma­te­ri­a­ler om­fat­ter an­skaf­fel­ses­pris med til­læg af hjem­ta­gel­ses­om­kost­nin­ger. Kost­pris for frem­stil­le­de fær­dig­va­rer og va­rer un­der frem­stil­ling om­fat­ter kost­pris for rå­va­rer og hjæl­pe­ma­te­ri­a­ler Net­to­rea­li­sa­tions­vær­di­en for va­re­be­hold­nin­ger op­gø­res som for­ven­tet salgs­pris med fra­drag af så­vel fær­dig­gø­rel­ses­om­kost­nin­ger som om­kost­nin­ger, der af­hol­des for at ef­fek­tu­e­re sal­get. Net­to­re­a­li­sa­tions­vær­di­en fast­sæt­tes un­der hen­syn­ta­gen til om­sæt­te­lig­hed, ku­rans og ud­vik­ling i for­ven­tet salgs­pris. InventoriesInventories are measured at cost according to the FIFO method. In cases when the net realisable value of the inventories is lower than the cost, the latter is written down for impairment to this lower value. Costs of goods for resale, raw materials, and consumables comprise acquisition costs plus delivery costs. Costs of manufactured goods and work in progress comprise the cost of raw materials and consumables. The net realisable value for inventories is recognised as the estimated selling price less costs of completion and selling costs. The net realisable value is determined with due consideration of negotiability, obsolescence, and the development of expected market prices. TilgodehavenderTil­go­de­ha­ven­der må­les til amor­ti­se­ret kost­pris, hvil­ket sæd­van­lig­vis sva­rer til no­mi­nel vær­di. Der ned­skri­ves til net­to­re­a­li­sa­tions­vær­di­en med hen­blik på at i­mø­de­gå for­ven­te­de tab.  ReceivablesReceivables are measured at amortised cost, which usually corresponds to nominal value. In order to meet expected losses, impairment takes place at the net realisable value.  PeriodeafgrænsningsposterPe­ri­o­de­af­græns­nings­pos­ter, som er ind­reg­net under ak­ti­ver, om­fat­ter af­hold­te om­kost­nin­ger ved­rø­ren­de ef­ter­føl­gen­de regn­skabs­år. PrepaymentsPrepayments recognised under assets comprise incurred costs concerning the following financial year. Likvide beholdningerLi­kvi­de be­hold­nin­ger om­fat­ter in­de­stå­en­der i pen­ge­in­sti­tut­ter. Cash and cash equivalentsCash and cash equivalents comprise cash at bank. EgenkapitalOverkurs ved emissionOver­kurs ved emis­sion om­fat­ter be­løb, der er ind­be­talt som over­kurs i hen­hold til teg­ning af ka­pi­tal­an­dele. Om­kost­nin­ger ved en gen­nem­ført emis­sion fra­dra­ges i over­kurs­be­lø­bet. Over­kurs­re­ser­ven kan be­nyttes til ud­bytte, fonds­emis­sion og dæk­ning af un­der­skud. Re­ser­ve for op­skriv­nin­gerUn­der re­ser­ve for op­skriv­nin­ger ind­reg­nes op­skriv­nin­ger på grun­de og byg­nin­ger med fra­drag af ud­skudt skat. Re­ser­ven re­du­ce­res, når op­skrev­ne byg­nin­ger re­du­ce­res i vær­di som føl­ge af af­skriv­nin­ger. Re­duk­tio­nen ud­gør for­skel­len mel­lem af­skriv­ning på grund­lag af byg­nin­ger­nes om­vur­de­re­de regn­skabs­mæs­si­ge vær­di og af­skriv­ning på grund­lag af byg­nin­ger­nes op­rin­de­li­ge kost­pris. Re­ser­ven op­lø­ses helt eller del­vis ved salg af grunde og byg­nin­ger og for­mind­skes ved ned­skriv­ning af grun­de og byg­nin­ger. Re­ser­ve for net­to­op­skriv­ning ef­ter den in­dre vær­dis me­to­deRe­ser­ve for net­to­op­skriv­ning ef­ter in­dre vær­dis me­to­de om­fat­ter net­to­op­skriv­ning af ka­pi­tal­an­de­le i til­knyt­te­de virk­somheder, as­so­ci­e­re­de virk­som­he­der og ka­pi­tal­in­te­res­ser i for­hold til kost­pris. Re­ser­ven kan eli­mi­ne­res ved un­der­skud, re­a­li­sation af ka­pi­tal­an­de­le el­ler æn­dring i regn­skabs­mæs­si­ge skøn. Re­ser­ven kan ik­ke ind­reg­nes med et ne­ga­tivt beløb. Re­ser­ve for ud­vik­lings­om­kost­nin­gerRe­ser­ve for ud­vik­lings­om­kost­nin­ger om­fat­ter ind­reg­ne­de ud­vik­lings­om­kost­nin­ger med fra­drag af til­knyt­te­de ud­skudte skat­te­for­plig­tel­ser. Re­ser­ven kan ik­ke be­nyt­tes til ud­byt­te el­ler dækning af un­der­skud. Re­ser­ven re­du­ce­res el­ler op­lø­ses, hvis de ind­reg­ne­de ud­vik­lings­om­kost­nin­ger af­skri­ves el­ler ud­går af virk­som­he­dens drift. Det­te sker ved over­før­sel di­rek­te til egen­ka­pi­ta­lens frie re­ser­ver. Re­ser­ve for va­lu­ta­kurs­om­reg­ningRe­ser­ve for va­lu­ta­kurs­om­reg­ning op­står ved om­reg­ning af regn­skabs­pos­ter i uden­landsk va­lu­ta. Reserven opløses samtidig med, at vær­di­re­gu­le­rin­ger­ne rea­li­se­res el­ler til­ba­ge­fø­res. Re­ser­ven er ikke bun­den. EquityShare premiumShare premium comprises premium payments made in connection with the issue of shares. Costs incurred for carrying through an issue are deducted from the premium. The premium reserve can be used for dividend, for issuing bonus shares, and for covering losses. Revaluation reserveRevaluations of property less deferred tax are recognised under the revaluation reserve. The reserve is reduced when the value of revalued property is reduced due to depreciation. The reduction represents the difference between depreciation based on the revalued carrying amount of the property and depreciation based on the original cost of the property. The reserve is partly or totally dissolved on the sale of the property and reduced as a result of impairment loss on property. Reserve for net revaluation according to the equity methodThe reserve for net revaluation according to the equity method comprises net revaluation of equity investments in subsidiaries, associates and equity interests proportional to cost. The reserve may be eliminated in the event of losses, realisation of equity investments, or changes in the accounting estimates. The reserve cannot be recognised by a negative amount. Reserve for development costsThe reserve for development costs comprises recognised development costs less related deferred tax liabilities. The reserve cannot be used as dividends or for covering losses. The reserve is reduced or dissolved if the recognised development costs are amortised or abandoned. This is done by direct transfer to the distributable reserves of the equity. Reserve for foreign currency translationThe reserve for foreign currency translation arises when translating accounting items in foreign currency. The reserve is dissolved once the value adjustments have been applied or reversed. The reserve is distributable. UdbytteUd­byt­te, som for­ven­tes ud­be­talt for året, vi­ses som en sær­skilt post un­der egen­ka­pi­ta­len. DividendDividend expected to be distributed for the year is recognised as a separate item under equity. Selskabsskat og udskudt skatAk­tu­el­le skat­te­for­plig­tel­ser og til­go­de­ha­ven­de ak­tu­el skat ind­reg­nes i ba­lan­cen som be­reg­net skat af årets skat­te­plig­ti­ge ind­komst, re­gu­le­ret for skat af tid­li­ge­re års skat­te­plig­ti­ge ind­kom­ster og for be­tal­te acon­to­skat­ter. Ud­skudt skat må­les ef­ter den ba­lan­ce­ori­en­te­re­de gælds­me­to­de af mid­ler­ti­di­ge for­skel­le mel­lem regn­skabs­mæs­sig og skat­te­mæs­sig vær­di af ak­ti­ver og for­plig­tel­ser op­gjort på grund­lag af den plan­lag­te an­ven­del­se af ak­ti­vet hen­holds­vis af­vik­ling af for­plig­tel­sen. Ud­skudt skat må­les til net­to­rea­li­sa­tions­vær­di. Ud­skudt skat må­les på grund­lag af de skat­te­reg­ler og skat­te­sat­ser i de re­spek­ti­ve lan­de, der med ba­lan­ce­da­gens lov­giv­ning vil væ­re gæl­den­de, når den ud­skud­te skat for­ven­tes ud­løst som ak­tu­el skat. Æn­dring i ud­skudt skat som føl­ge af æn­drin­ger i skat­te­sat­ser ind­reg­nes i re­sul­tat­op­gø­rel­sen bort­set fra pos­ter, der fø­res di­rek­te på egen­ka­pi­ta­len. Ud­skud­te skat­te­ak­ti­ver, her­un­der skat­te­vær­di­en af frem­før­sels­be­ret­ti­get skat­te­mæs­sigt un­der­skud, må­les til den vær­di, hvor­til ak­ti­vet for­ven­tes at kun­ne rea­li­se­res, en­ten ved ud­lig­ning i skat af frem­ti­dig ind­tje­ning el­ler ved mod­reg­ning i ud­skud­te skat­te­for­plig­tel­ser in­den for sam­me ju­ri­dis­ke skat­te­en­hed. Even­tu­el­le ud­skud­te net­to­skat­te­ak­ti­ver må­les til net­to­rea­li­sa­tions­vær­di. Income tax and deferred taxCurrent tax liabilities and current tax receivable are recognised in the statement of financial position as calculated tax on the taxable income for the year, adjusted for tax of previous years' taxable income and for tax paid on account. Deferred tax is measured on the basis of temporary differences in assets and liabilities with a focus on the statement of financial position. Deferred tax is measured at net realisable value. Deferred tax is measured based on the tax rules and tax rates applying under the legislation prevailing in the respective countries on the reporting date when the deferred tax is expected to be released as current tax. Changes in deferred tax due to changed tax rates are recognised in the income statement, except for items included directly in the equity. Deferred tax assets, including the tax value of tax losses allowed for carryforward, are recognised at the value at which they are expected to be realisable, either by settlement against tax of future earnings or by set-off in deferred tax liabilities within the same legal tax unit. Any deferred net tax assets are measured at net realisable value. GældsforpligtelserØvrige gælds­for­plig­tel­ser, som om­fat­ter gæld til le­ve­ran­dø­rer, til­knyt­te­de virk­som­he­der samt an­den gæld, må­les til amor­ti­se­ret kost­pris, hvil­ket sædvan­lig­vis sva­rer til no­mi­nel vær­di. Liabilities other than provisionsOther liabilities concerning payables to suppliers, group enterprises, and other payables are measured at amortised cost which usually corresponds to the nominal value. PeriodeafgrænsningsposterUn­der pe­ri­o­de­af­græns­nings­pos­ter ind­reg­nes mod­tag­ne be­ta­lin­ger ved­rø­ren­de ind­tæg­ter i de ef­ter­føl­gen­de år. Deferred incomePayments received concerning future income are recognised under deferred income.